Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Scholar Rock Holding Corp | 620,055 | reported | 16 Apr 2026 | tx 6+757,088−26,966 |
| TScan Therapeutics, Inc. | 67,000 | reported | 20 May 2026 | tx 4+199,000 |
| ROCKET PHARMACEUTICALS, INC. | 23,944 | reported | 13 Jun 2024 | tx 3+56,426 |
| Neurogene Inc. | 12,050 | reported | 20 Feb 2026 | tx 1+12,050 |
| X4 Pharmaceuticals, Inc | 6,000 | reported | 09 Jun 2025 | tx 3+136,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | TScan Therapeutics, Inc. | 67,000 | 0.00 USD | deriv |
| 16 Apr 2026 | SALE | Scholar Rock Holding Corp | 10,220 | 49.57 USD | |
| 20 Feb 2026 | GRANT_AWARD | Neurogene Inc. | 12,050 | 0.00 USD | deriv |
| 09 Feb 2026 | GRANT_AWARD | Scholar Rock Holding Corp | 47,021 | 0.00 USD | |
| 13 Jan 2026 | SALE | Scholar Rock Holding Corp | 16,746 | 42.70 USD | |
| 30 Jun 2025 | GRANT_AWARD | TScan Therapeutics, Inc. | 67,000 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 1,500 | 0.00 USD | |
| 02 May 2025 | GRANT_AWARD | Scholar Rock Holding Corp | 110,067 | 0.00 USD | deriv |
| 27 Apr 2025 | GRANT_AWARD | Scholar Rock Holding Corp | 100,000 | 0.00 USD | |
| 27 Apr 2025 | GRANT_AWARD | Scholar Rock Holding Corp | 500,000 | 0.00 USD | |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 23,944 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | TScan Therapeutics, Inc. | 47,500 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 45,000 | 0.00 USD | |
| 07 Dec 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 11,960 | 0.00 USD | deriv |
| 07 Dec 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 20,522 | 0.00 USD | deriv |
| 06 Dec 2023 | GRANT_AWARD | TScan Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 16 Oct 2023 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 90,000 | 0.00 USD |